Top Ranked Momentum Stocks to Buy for September 20th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 20th:


Iridium Communications Inc.


IRDM

: This provider of mobile voice and data communications services and product has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 52.4% over the last 60 days.

Iridium Communications’ shares gained nearly 9% over the last one month against the S&P 500’s decline of nearly 1%. The company possesses a

Momentum Score

of A.


Aluminum Corporation of China Limited


ACH

: This manufacturer and seller of alumina, primary aluminum, and energy products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.2% over the last 60 days.

Aluminum Corporation of China’s shares gained 42.8% over the last one month. The company possesses a Momentum Score of A.


Goodrich Petroleum Corporation


GDP

: This independent oil and natural gas company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 30% over the last 60 days.

Goodrich Petroleum’s shares gained 37% over the last one month. The company possesses a Momentum Score of A.


Extraction Oil & Gas, Inc.


XOG

: This independent oil and gas company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.7% over the last 60 days.

Extraction Oil & Gas’ shares gained 23.5% over the last one month. The company possesses a Momentum Score of A.

See the


full list of top ranked stocks here

Learn more about the


Momentum score and how it is calculated here


.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.


See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report


To read this article on Zacks.com click here.


Zacks Investment Research